Conventional Hemodialysis Versus Post-Dilution Hemofiltration in Incident RRT

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-06

Study Completion Date

2021-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with chronic kidney disease (CKD) with criteria for renal replacement therapy (RRT) including uremic syndrome, have a stable state of hyperosmolarity due to urea despite not being an osmotically inactive ion. Also, these patients have alterations in urea transporters in the central nervous system (CNS) conferring a risk of neurological involvement due to an abrupt decrease in serum urea causing manifestations of the post-dialytic syndrome.

Hemodialysis results in rapid removal of urea from the blood, much faster than the equilibrium rate between the brain and the bloodstream through the blood-brain barrier, resulting in an osmotic gradient that favors movement from water to the brain, causing cerebral edema, intracranial hypertension and dialysis-associated imbalance syndrome. Conventional hemodialysis (HD) uses diffusion and primarily decreases small solutes, while hemofiltration (HF) is based on convection that provides clearance mainly of medium-size molecules and small solutes with a slower rate of reduction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Online Hemodiafiltration vs Conventional Hemodialysis in Acute Kidney Injury

NCT04525092

Acute Kidney Injury

COMPLETED NA

Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function

NCT03874117

Hemodialysis Kidney Failure, Chronic

COMPLETED NA

Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis

NCT01062984

Acute Renal Failure

COMPLETED NA

Clinical Trial Comparing Continuous Versus Intermittent Hemodialysis in ICU Patients

NCT01228123

Acute Renal Failure

COMPLETED PHASE2/PHASE3

Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal

NCT03938285

Hemodiafiltration Chronic Kidney Disease Requiring Chronic Dialysis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Currently, there is little information about which is the safest modality in the first session of intermittent hemodialysis. Other than dialysis-associated imbalance syndrome, there is no evidence exploring the neurocognitive effects of the first hemodialysis session. Cognitive impairment is defined as a new deficit in two or more areas of cognitive function and its progression is associated with impaired kidney function. Most of the dysfunctions reported are in the domains of orientation, attention and executive functions. Therefore, the recognition of cognitive impairment can be done with tools such as the Minimental State Examination (MMSE) and the Montreal Cognitive Assessment (MOCA) test. Brain magnetic resonance imaging (MRI) can identify brain lesions such as 'silent' infarcts, microbleeds and white matter abnormalities in patients with CKD with and without RRT. Diffusion-weighted MRI before and after HD has shown brain edema in rats with dialysis-associated imbalance syndrome. In fact, there is evidence from brain MRI that before first HD session patients have interstitial cerebral edema, which worsens after the first HD treatment.

Because there is no clear evidence to support the choice of the modality in the first session and the prescription is still based on personal experiences and shared views. Therefore, we conducted a pilot study to determine the safest hemodialysis modality with the lowest risks and neurocognitive effects for patients with CKD and first HD treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dialysis; Complications Hemodialysis Complication Cerebral Edema Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hemodialysis

Conventional hemodialysis

Group Type NO_INTERVENTION

No interventions assigned to this group

Hemofiltration

Postdilutional hemofiltration

Group Type EXPERIMENTAL

Hemofiltration

Intervention Type OTHER

Postdilutional Hemofiltration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hemofiltration

Postdilutional Hemofiltration

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 17 years
* Both gender
* CKD stage 5 with clinical or biochemical criteria to kidney replacement therapy initiation that includes:
* Urea nitrogen \> 80 mg/dl
* Hyperkalemia
* Fluid overload
* Metabolic acidosis (ph \< 7.2 and/or bicarbonate \<12)

Exclusion Criteria

* Visual disturbances
* Altered mental status at enrollment
* Hypothyroidism without optimal supplementation
* Advanced neoplasia
* Acute kidney injury

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No